Global PSA Test Market Growth 2023-2029

Global PSA Test Market Growth 2023-2029

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.
LPI (LP Information)' newest research report, the “PSA Test Industry Forecast” looks at past sales and reviews total world PSA Test sales in 2022, providing a comprehensive analysis by region and market sector of projected PSA Test sales for 2023 through 2029. With PSA Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PSA Test industry.
This Insight Report provides a comprehensive analysis of the global PSA Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PSA Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global PSA Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PSA Test and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PSA Test.
The global PSA Test market size is projected to grow from US$ 499.9 million in 2022 to US$ 861.8 million in 2029; it is expected to grow at a CAGR of 861.8 from 2023 to 2029.
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.
This report presents a comprehensive overview, market shares, and growth opportunities of PSA Test market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
CLIA
ELISA
Others
Segmentation by application
Screening
Post-treatment Monitoring
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Key Questions Addressed in this Report
What is the 10-year outlook for the global PSA Test market?
What factors are driving PSA Test market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PSA Test market opportunities vary by end market size?
How does PSA Test break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.